Skip to content

Relation Between AI-QCA and Cardiac PET

Relation Between Artificial Intelligence (AI)-Assisted Quantitative Coronary Angiography and Positron Emission Tomography-Derived Myocardial Blood Flow

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06397820
Acronym
AI-CARPET
Enrollment
168
Registered
2024-05-03
Start date
2021-09-01
Completion date
2024-12-31
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Coronary Artery Stenosis

Keywords

Invasive coronary angiography, Cardaic positron Emission Tomography, Artificial Intelligence, Quantitative Coronary Angiography

Brief summary

The aim of the study is to evaluate the clinical implications of artificial Intelligence (AI)-assisted quantitative coronary angiography (QCA) and positron emission tomography (PET)-derived myocardial blood flow in clinically indicated patients.

Detailed description

Percutaneous coronary angiography (CAG) is a standard method for evaluating coronary artery disease. Traditionally, a reduction in the luminal diameter of the coronary arteries by 50% or more during angiography has been considered a significant stenotic lesion. However, the assessment of coronary artery stenosis is usually based on visual estimation by the operator in daily routine clinical practice, which interferes with the objective evaluation. Quantitative coronary angiography (QCA) has been developed to overcome this limitation. This technique involves the software-based analysis of coronary images obtained through CAG. The previous study showed that there was low concordance between the QCA and visual estimation of coronary artery stenosis (Kappa=0.63) and a reclassification rate of approximately 20%. Furthermore, visual assessments tended to overestimate the degree of coronary artery stenosis, particularly in complex lesions such as bifurcation lesions. However, there are some limitations to adopting QCA in our daily routine practice. The QCA cannot analyze coronary images on-site and is not fully automated, requiring manual adjustments by humans. Recent advancements have led to the development of artificial intelligence (AI)-based QCA software, which achieves complete automation in the analysis process and provides real-time objective evaluations of coronary artery stenosis. This study aims to examine the clinical significance of AI-QCA by assessing the correlation between the degree of coronary stenosis detected by AI-QCA and myocardial blood flow abnormalities observed in 13NH3-Ammonia PET scans in patients with coronary artery disease.

Interventions

DEVICEPercutaneous coronary intervention (PCI)

Revascularization by percutaneous coronary intervention for vessels with decreased PET-derived flow indexes

Sponsors

Chonnam National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject must be ≥18 years 2. Patients suspected with CAD or ischemic heart disease 3. Patients undergoing CAG and cardiac PET for evaluation of severity of coronary artery disease

Exclusion criteria

1. Poor imaging quality of CAG and PET which were not available for core-lab analysis 2. Chronic total occlusion 3. Time interval was more than \>3 months between CAG and PET 4. History of coronary artery bypass grafting 5. History of acute myocardial infarction or recent myocardial infarction 6. Heart failure (left ventricular ejection fraction \<40%)

Design outcomes

Primary

MeasureTime frameDescription
Correlation between diameter stenosis by AI-QCA and PET-driven RFRImmediate after AI-QCA and PET examsPerformance of AI-QCA predicting for PET-driven RFR
Correlation between diameter stenosis by AI-QCA and PET-driven stress MBFImmediate after AI-QCA and PET examsPerformance of AI-QCA predicting for PET-driven stress MBF

Secondary

MeasureTime frameDescription
Correlation between diameter stenosis by AI-QCA and PET-driven semi-quantitative markers of ischemiaImmediate after AI-QCA and PET examsPerformance of AI-QCA predicting for PET-driven semi-quantitative markers of ischemia
All-cause death1 year after last patient enrollmentAll-cause death
Cardiovascular death1 year after last patient enrollmentCardiovascular death
Myocardial infarction1 year after last patient enrollmentAny myocardial infarction, defined by Forth Universal definition of myocardial infarction
Rate of target lesion revascularization1 year after last patient enrollmentTarget lesion revascularization
Correlation between diameter stenosis by AI-QCA and PET-driven coronary flow reserve (CFR)Immediate after AI-QCA and PET examsPerformance of AI-QCA predicting for PET-driven CFR
Rate of any revascularization1 year after last patient enrollmentAny revascularization
Rate of stent thrombosis1 year after last patient enrollmentDefinite or probable stent thrombosis, defined by ARC II definition
Rate of cerebrovascular accident1 year after last patient enrollmentCerebrovascular accident
Major adverse cerebrocardiovascular event (MACCE)1 year after last patient enrollmentA composite of death, myocardial infarction, any revascularization, and cerebrovascular accident
Rate of target vessel revascularization1 year after last patient enrollmentTarget vessel revascularization
Correlation between diameter stenosis by AI-QCA and PET-driven coronary flow capacity (CFC)Immediate after AI-QCA and PET examsPerformance of AI-QCA predicting for PET-driven CFC

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026